Citigroup
DERM icon

Citigroup’s Journey Medical DERM Stock Holding History

Citigroup’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.08K Buy
1,084
+758
+233% +$5.88K ﹤0.01% 5261
2025
Q4 		$2.51K Sell
326
-193
-37% -$1.51K ﹤0.01% 5418
2025
Q3 		$3.69K Sell
519
-3,791
-88% -$27.5K ﹤0.01% 5319
2025
Q2 		$30.9K Buy
+4,310
New +$29.8K ﹤0.01% 4970

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's DERM Position: Q1 2026 in Review

Citigroup increased its Journey Medical (DERM) stake by 233% in Q1 2026, buying an estimated $5.88K and bringing the position to 1,084 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5261.

Citigroup first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $30.9K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Citigroup held 1,084 shares of Journey Medical worth $5.08K as of Q1 2026.
  • Citigroup bought 758 Journey Medical shares in Q1 2026, an estimated $5.88K.
  • Journey Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5261 holding.
  • Citigroup first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Citigroup's Journey Medical position peaked at $30.9K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.